Angelo M. Scanu

Q: What Schools Are Affiliated With Angelo M. Scanu

Angelo M. Scanu is affiliated with the following schools: University of Milan, University of Chicago

Angelo M. Scanu's AcademicInfluence.com Rankings

Angelo M. Scanu

Biology

#4820

World Rank

#7137

Historical Rank

Molecular Biology

#397

World Rank

#404

Historical Rank

Biochemistry

#519

World Rank

#607

Historical Rank

biology Degrees

Download Badge

Biology

Angelo M. Scanu's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Biochemistry University of California, Berkeley

Why Is Angelo M. Scanu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Angelo M. Scanu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen (1987) (1814)
Lipoprotein (a). Heterogeneity and biological relevance. (1990) (573)
A potential basis for the thrombotic risks associated with lipoprotein(a) (1989) (570)
Lipoprotein(a), fibrin binding, and plasminogen activation. (1990) (467)
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. (1987) (426)
Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins. (1971) (405)
Structure of human serum lipoproteins inferred from compositional analysis. (1977) (294)
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). (2000) (282)
Lipoprotein(a). A genetic risk factor for premature coronary heart disease. (1992) (270)
Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity. (1969) (264)
Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). (1986) (260)
Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. (1984) (258)
Lipoprotein(a) and atherosclerosis. (1991) (212)
Forms of human serum high density lipoprotein protein. (1966) (197)
Structural and functional aspects of lipoproteins in living systems. (1969) (190)
Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. (1992) (158)
Structural studies on serum lipoproteins (1972) (144)
Isolation and properties of lipoproteins from normal rat serum. (1969) (142)
TRITON HYPERLIPEMIA IN DOGS : I. IN VITRO EFFECTS OF THE DETERGENT ON SERUM LIPOPROTEINS AND CHYLOMICRONS (1961) (137)
HDL: bridging past and present with a look at the future (2008) (136)
Precautionary measures for collecting blood destined for lipoprotein isolation. (1986) (135)
Enzyme-linked immunoassay for Lp[a]. (1989) (135)
Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay. (1976) (133)
Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)* (2003) (130)
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. (2009) (129)
Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum. (1983) (128)
Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease. (1983) (124)
On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction 3). (1972) (123)
Effect of triton on lipoprotein lipase of rat plasma. (1957) (122)
Factors affecting lipoprotein metabolism. (1965) (119)
Serum lipoproteins structure and function. (1972) (113)
Isolation of apolipoprotein(a) from lipoprotein(a). (1985) (108)
Apolipoproteins and the structural organization of plasma lipoproteins: human plasma high density lipoprotein-3. (1979) (106)
In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. (1980) (106)
SEPARATION AND CHARACTERIZATION OF HUMAN SERUM CHYLOMICRONS (1959) (106)
Lipoprotein(a) Levels in Black and White Children and Adolescents With IDDM (1991) (106)
Isolation, properties, and mechanism of in vitro action of lecithin: cholesterol acyltransferase from human plasma. (1979) (104)
Biochemistry and biology of plasma lipoproteins (1986) (103)
On the structure of human serum low density lipoprotein. (1972) (101)
Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. (1976) (101)
Effects of ultracentrifugation on the human serum high-density (1.063 less than p less than 1.21 g/ml) lipoprotein. (1966) (97)
A study of the abnormal lipoproteins in abetalipoproteinemia. (1974) (95)
Separation and characterization of the protein moiety of human α1-lipoprotein (1958) (90)
In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity. (1983) (88)
Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. (1994) (82)
Structure of human serum lipoproteins in solution. II. Small-angle x-ray scattering study of HDL3 and LDL. (1976) (82)
Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein. (1991) (82)
Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins. (1971) (76)
Fractionation of human serum lipoproteins by single-spin gradient ultracentrifugation: quantification of apolipoproteins B and A-1 and lipid components. (1977) (76)
Binding of human serum high density lipoprotein apoprotein with aqueous dispersions of phospholipids. (1967) (75)
Degradation and reassembly of a human serum high-density lipoprotein. Evidence for differences in lipid affinity among three classes of polypeptide chains. (1970) (74)
Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. (1992) (73)
Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions. (1976) (73)
Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37). (1993) (71)
On the subunit structure of the protein of human serum high density lipoprotein. II. A study of Sephadex fraction IV. (1972) (71)
Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. (1985) (71)
Lipoprotein(a): structure, biology, and clinical relevance. (1991) (69)
On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. (1982) (69)
Isolation and characterization of subunit polypeptides from apoproteins of rat serum lipoprotein. (1971) (69)
Solubilization and properties of the apoproteins of the very low- and low-density lipoproteins of human serum. (1966) (69)
Lipoprotein(a) and the atherothrombotic process: Mechanistic insights and clinical implications (2003) (68)
Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients. (1992) (65)
The Biochemistry of atherosclerosis (1979) (64)
Properties of human serum low density lipoproteins after modification by succinic anhydride. (1968) (64)
Interaction of Lp(a) with Plasminogen Binding Sites on Cells (1995) (63)
FURTHER CHARACTERIZATION OF THE HUMAN SERUM D 1.063-1.21, α1-LIPOPROTEIN* (1962) (63)
TRITON HYPERLIPEMIA IN DOGS II. ATHEROSCLEROSIS, DIFFUSE LIPIDOSIS, AND DEPLETION OF FAT STORES PRODUCED BY PROLONGED ADMINISTRATION OF THE NON-IONIC SURFACE-ACTIVE AGENT (1961) (62)
7 – Serum Lipoproteins (1975) (62)
Biosynthesis of human preproapolipoprotein A-II. (1983) (62)
Small-angle x-ray scattering of human serum high-density lipoproteins. (1972) (60)
A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). (1994) (59)
An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultracentrifugation. (1981) (59)
Isolation, molecular properties, and kinetic characterization of lipoprotein lipase from rat heart. (1977) (59)
Reassembly in vitro of a serum high-density lipoprotein. (1970) (59)
Lp(a) lipoprotein--coping with heterogeneity. (2003) (58)
Serum low density lipoproteins with mitogenic effect on cultured aortic smooth muscle cells. (1982) (57)
In vitro reciprocal exchange of apoproteins and nonpolar lipids between human high density lipoproteins and an artificial triglyceride-phospholipid emulsion (Intralipid). (1982) (57)
Kringle-dependent structural and functional polymorphism of apolipoprotein (a). (1995) (56)
Uptake of endogenous cholesterol by a synthetic lipoprotein. (1986) (56)
Plasma cholesterol synthesis using deuterated water in humans: effect of short-term food restriction. (1988) (56)
Stimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a) (2001) (54)
On the geometrical arrangement of the protein subunits of human serum low-density lipoprotein: evidence for a dodecahedral model. (1969) (53)
High-resolution NMR spectra of high-density serum lipoproteins. (1969) (53)
Recombining capacity toward lipids of the protein moiety of human serum alpha 1-lipoprotein. (1960) (52)
Atherothrombogenicity of lipoprotein(a): the debate. (1998) (51)
The serum high density lipoproteins of Macacus rhesus. I. Isolation, composition, and properties. (1973) (51)
The serum high density lipoproteins of Macacus rhesus. II. Isolation, purification, and characterization of their two major polypeptides. (1973) (51)
Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal. (1991) (51)
Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]. (1996) (49)
Measurement of serum apolipoprotein B by radioimmunoassay (1978) (48)
Enzymatic probes of lipoprotein structure. Hydrolysis of human serum low density lipoprotein-2 by phospholipase A2. (1976) (47)
Comparison of the lysine binding functions of lipoprotein(a) and plasminogen. (1993) (47)
Modification of low density lipoproteins by polymorphonuclear cell elastase leads to enhanced uptake by human monocyte-derived macrophages via the low density lipoprotein receptor pathway. (1988) (45)
On the conformational instability of human serum low-density lipoprotein: effect of temperature. (1969) (45)
Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase (1997) (44)
Study of abnormal plasma low-density lipoprotein in rhesus monkeys with diet-induced hyperlipidemia. (1976) (44)
Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations. (2008) (44)
Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations. (1997) (43)
Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a]. (1990) (43)
Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipoprotein A-I in solution. (1980) (43)
Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. (1995) (42)
Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor. (1988) (42)
Serum High-Density Lipoprotein: Effect of Change in Structure on Activity of Chicken Adipose Tissue Lipase (1966) (42)
Evidence for a Proinflammatory and Proteolytic Environment in Plaques From Endarterectomy Segments of Human Carotid Arteries (2004) (41)
Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptor function. (1990) (41)
Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. (1994) (41)
Neutron scattering study of human serum low density lipoprotein. (1975) (40)
Structural and Functional Changes of Rhesus Serum Low Density Lipoproteins During Cycles of Diet‐Induced Hypercholesterolemia (1982) (39)
Molecular weight and subunit structure of human serum high density lipoprotein after chemical modification by succinic anhydride (1968) (38)
Functional Roles of Plasma High Density Lipoprotein (1982) (38)
31-P nuclear magnetic resonance studies on serum low and high density lipoproteins: effect of paramagnetic ion. (1975) (38)
Nuclear magnetic resonance studies on serum low density lipoproteins (LDL2). (1969) (37)
Apolipoprotein(a) Binds via Its C-terminal Domain to the Protein Core of the Proteoglycan Decorin (1998) (37)
Kinetic study of the action of snake venom phospholipase A2 on human serum high density lipoprotein 3. (1976) (37)
Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes. (1994) (36)
Normal serum and lipoprotein-deficient serum give different expressions of excitability, corresponding to different stages of differentiation, in chicken cardiac cells in culture. (1982) (36)
In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells. (1986) (36)
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes. (1996) (35)
Characterization and measurement of human apolipoprotein A-II by radioimmunoassay. (1980) (35)
STUDIES ON THE ANTIGENICITY OF β- AND α1-LIPOPROTEINS OF HUMAN SERUM (1958) (34)
Structural and functional polymorphism of lipoprotein(a): biological and clinical implications. (1995) (34)
Apolipoprotein(a): structure and biology. (2001) (33)
A protein component of serum high density lipoprotein with CO-factor activity against purified lipoprotein lipase. (1970) (33)
The proteins of plasma lipoproteins: properties and significance. (1973) (32)
Hypobetalipoproteinemia: Clinical and biochemical description of a new kindred with ‘Friedreich”s ataxia' (1974) (32)
Inhibition of human lymphocyte E-rosette formation by oxygenated sterols. (1979) (32)
The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events (2001) (32)
Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. (1988) (32)
Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein (a) levels (2002) (32)
Asymmetry of apolipoprotein A-I in solution as assessed from ultracentrifugal, viscometric, and fluorescence polarization studies. (1979) (31)
EFFECT OF APOLIPOPROTEIN A‐II ON THE STRUCTURE OF HIGH‐DENSITY LIPOPROTEINS: RELATIONSHIP TO THE ACTIVITY OF LECITHIN: CHOLESTEROL ACYL TRANSFERASE IN VITRO * (1980) (31)
Properties of rooster serum high density lipoproteins. (1975) (31)
Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts. (1994) (30)
Serum lipoproteins modulate oxygenated sterol insertion into human red cell membranes. (1981) (30)
The selective lipid-lowering effect of vegetarianism on low density lipoproteins in a cross-over experiment. (1982) (30)
Isolation and characterization of the three major low density lipoproteins from normolipidemic rhesus monkeys (Macaca mulatta). (1979) (29)
Chimpanzee (Pan troglodytes) serum high density lipoproteins. Isolation and properties of their two major apolipoproteins. (1974) (29)
Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample (2005) (29)
On the temperature dependence of the conformation of human serum high density lipoprotein. (1969) (28)
Effect of glycation on the properties of lipoprotein(a). (1995) (28)
Interaction of human serum high density lipoprotein apoprotein with phospholipids. (1974) (28)
Isolation and characterization of a dog serum lipoprotein having apolipoprotein A-I as its predominant protein constituent. (1976) (28)
Effect of phospholipids on lipoprotein lipase activation in vitro. (1973) (27)
Properties of human apolipoprotein A-I at the air-water interface. (1980) (27)
Macrophage Metalloelastase, MMP-12, Cleaves Human Apolipoprotein(a) in the Linker Region between Kringles IV-4 and IV-5 (1999) (26)
In vitro mass: activity distribution of lecithin--cholesterol acyltransferase among human plasma lipoproteins. (1982) (26)
Studies on the conformation of human serum high-density lipoproteins HDL2 and HDL3. (1965) (26)
Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. (1990) (25)
Human Serum Low-density Lipoprotein Protein: its Conformation studied by Circular Dichroism (1968) (25)
Abnormalities of High Density Lipoproteins in Homozygous Familial Hyperchoiesteroiemia (1984) (25)
On the structure of human serum high-density lipoprotein: studies by the technique of circular dichroism. (1968) (25)
STRUCTURE OF HUMAN SERUM LIPOPROTEINS (1972) (25)
31P nuclear magnetic resonance: application to the study of human serum high density lipoproteins. (1974) (25)
Familial hypercholesterolemia in a rhesus monkey pedigree: molecular basis of low density lipoprotein receptor deficiency. (1990) (24)
Proteolytic events affecting plasma apolipoproteins at the co- and post-translational levels and after maturation. (1984) (23)
Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. (1999) (23)
Update on lipoprotein (a) (1991) (23)
Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol protease. (1984) (23)
Changes in Plasma Triglyceride Levels Shift Lipoprotein(a) Density in Parallel With That of LDL Independently of Apolipoprotein(a) Size (2001) (23)
Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations. (1993) (22)
Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a). (1993) (22)
Apolipoprotein (a) fragments in relation to human carotid plaque instability. (2000) (22)
Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives. (2001) (22)
Effect of disulfide cleavage on the molecular weight of one of the major polypeptides of human serum high density lipoprotein (1971) (21)
Studies of the cyanogen bromide fragments of the apoprotein of human serum low density lipoproteins. (1978) (21)
The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low‐density lipoproteins and are probably of cellular origin (2009) (21)
Physicochemical characterization of Rhesus low density lipoproteins. (1975) (21)
Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts. (2010) (21)
Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin B. (1985) (21)
Recombination with lipids of the lipid-free protein from canine serum (d 1.063-1.21, alpha 1) lipoprotein. (1961) (20)
In vitro effect of Triton WR-1339 on canine plasma high density lipoproteins. (1984) (20)
Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins. (2001) (20)
Temperature transitions of lipid mixtures containing cholesterol esters. Relevance to the structural problem of serum high density lipoprotein. (1971) (20)
Apoproteins of bovine serum high density lipoproteins: isolation and characterization of the small-molecular-weight components (1976) (20)
Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of Sephadex fraction V from normal subjects and patients with abeta-lipoproteinemia. (1976) (20)
220 MHz Nuclear Magnetic Resonance Spectra of High Density Serum Lipoproteins (1969) (20)
Postprandial lipoprotein(a) response to a single meal containing either saturated or omega-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia. (1992) (20)
The effect of reduction and carboxymethylation on the circular dichroic spectra of two polypeptide classes of serum high density lipoprotein. (1970) (19)
Lipoprotein(a) as a cardiovascular risk factor. (1991) (19)
Action of alpha-phospholipase A2 on human serum high density lipoprotein-3: kinetic study of the reaction by 31P nuclear magnetic resonance spectroscopy. (1978) (19)
N-acetylcysteine and immunoreactivity of lipoprotein(a) (1991) (19)
Research on plasma lipoproteins: theoretical aspects and relevance to clinical medicine. (1973) (19)
Structural Determinants in the C-terminal Domain of Apolipoprotein E Mediating Binding to the Protein Core of Human Aortic Biglycan* (2000) (19)
Heterogeneity of lipoprotein (a): growing complexities. (1995) (18)
Advantages and limitations of density gradient ultracentrifugation in the fractionation of human serum lipoproteins: role of salts and sucrose. (1984) (18)
Proteolytic processing and compartmentalization of the primary translation products of mammalian apolipoprotein mRNAs. (1986) (18)
Attenuation of immunologic reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications. (1992) (18)
Lipoprotein(a), friedewald formula, and NCEP guidelines (2001) (18)
Continuous pH-stat titration method for the assay of lipoprotein lipase activity in vitro. (1974) (18)
Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E. (1994) (18)
High density lipoproteins influence cholesterol homeostasis in cultured virus-transformed human lymphoblastoid cells. Dependence on the lipoprotein concentration in the medium. (1982) (17)
Atherogenic diets and neutral-lipid organization in plasma low density lipoproteins. (1979) (17)
Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family. (1988) (17)
Optical rotatory dispersion and circular dichroism of phospholipase A2 and its zymogen from porcine pancreas. (1969) (17)
LP(a) as a marker for coronary heart disease risk (1991) (17)
Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved. (1982) (17)
In Vitro and In Vivo Interactions of Triton 1339 with Plasma Lipoproteins of Normolipidemic Rhesus Monkeys: Preferential Effects on High Density Lipoproteins (1984) (17)
Apolipoprotein A-II and structure of human serum high density lipoproteins. An approach by reassembly techniques. (1979) (16)
Plasma transport of lipids and lipoprotein proteins in dogs treated with triton WR-1339. (1962) (16)
The enzyme that cleaves apolipoprotein A-II upon in vitro incubation of human plasma high-density lipoprotein-3 with blood polymorphonuclear cells is an elastase. (1984) (16)
Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins. (1978) (15)
Response of Rhesus Serum High Density Lipoproteins to Cycles of Diet‐Induced Hypercholesterolemia (1984) (15)
Genetic basis and pathophysiological implications of high plasma Lp(a) levels (1992) (15)
Covalent structure of apolipoprotein A-II from Macaca mulatta serum high-density lipoproteins. (1976) (14)
Protein-protein and protein-lipid interactions in human serum high-density lipoprotein: an analysis by a spin label method. (1971) (14)
Effect of oxygenated sterol compounds on human bone marrow granulocytic progenitor cells. (1981) (14)
Plasma lipoproteins and coronary heart disease. (1978) (14)
Rapid isolation of apolipoprotein E from human plasma very low density lipoproteins by molecular sieve high performance liquid chromatography. (1983) (14)
APPLICATION OF THE TECHNIQUE OF ISOELECTRIC FOCUSING TO THE STUDY OF HUMAN SERUM LIPOPROTEINS AND THEIR APOPROTEINS * (1973) (14)
Effect of high-density lipoproteins with varying ratios of apolipoprotein A-I to apolipoprotein A-II on steroidogenesis by cultured rat ovary granulosa cells. (1985) (13)
The lipoproteins and arterial smooth muscle cells: cellular proliferation and morphology. (1977) (13)
Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells. (1996) (13)
Sedimentation behavior of native and reduced apolipoprotein A-II from human high density lipoproteins. (1978) (13)
Lipoprotein(a). Link between structure and pathology. (1992) (13)
Relationship Between the Properties of the Apo B Containing Low-Density Lipoproteins (LDL) of Normolipidemic Rhesus Monkeys and their Mitogenic Action on Arterial Smooth Muscle Cells Grown In Vitro (1980) (13)
Application of physical methods to the study of serum lipoproteins. (1974) (13)
Expression and purification of kringle 4-type 2 of human apolipoprotein (a) in Escherichia coli. (1992) (12)
Workshop on apolipoprotein quantification. (1983) (12)
Interaction of lipoprotein (a) with the extracellular matrix (1998) (12)
Properties and metabolic fate of two very low density lipoprotein subfractions from rhesus monkey serum. (1982) (12)
Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role (1992) (12)
Inhibition of oxygenated sterol entry into human red cells and lymphocytes by isolated serum lipoproteins. (1982) (12)
Electron microscopy of negatively stained and freeze-etched high density lipoprotein-3 from human serum. (1977) (11)
Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis. (1995) (11)
Structural changes in human serum high density lipoprotein-3 attending incubation with blood leukocytes. (1980) (11)
Identification of the active-site serine in human lecithin: cholesterol acyltransferase. (1987) (11)
Amplification of human APO(a) kringle 4-37 from blood lymphocyte DNA. (1993) (10)
Organization of unesterified cholesterol in high density lipoproteins probed by filipin. (1982) (10)
Proapolipoprotein-converting enzymes and high-density lipoprotein early events in biogenesis. (1987) (10)
Antigenic relatedness between human lecithin-cholesterol acyltransferase and phospholipases of the A2 family. (1986) (10)
Plasma lipoproteins: an overview (1986) (10)
Isolation and characterization of the cyanogen bromide fragments from apolipoprotein A‐II of Macacus rhesus serum high density lipoproteins: Comparison with the human product (1974) (9)
Lipoprotein(a): Looking ahead. (2005) (9)
Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes. (2010) (9)
[18] High-performance liquid chromatography of apolipoproteins (1986) (9)
Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance. (1984) (9)
Separation of beta lipoprotein from normal and hyperlipemic human sera. (1958) (9)
Apolipoprotein(a): structural and functional consequences of mutations in kringle type 10 (or kringle 4–37) (1994) (9)
Functional roles of plasma high density lipoproteins. (1982) (9)
Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2. (1988) (9)
Soluble and immobilized trypsin as structural probes of human plasma high-density lipoproteins: enzyme properties and kinetics of proteolysis. (1983) (9)
Plasma lipoprotein changes attending the intravenous administration of Triton WR-1339 in normolipidemic dogs: preferential effect on high density lipoproteins. (1985) (8)
Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogen (1997) (8)
Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. (1984) (8)
Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus. (1993) (8)
Dominant role of the C-terminal domain in the binding of apolipoprotein(a) to the protein core of proteoglycans and other members of the vascular matrix. (1999) (8)
Plasma lipoproteins: Structure, function, and regulation (1978) (8)
Plasma lipoprotein(a) and the Friedewald formula. (1989) (7)
Plasma lipoprotein structure (1977) (7)
Heterogeneity of the Protein Moiety of the Human Serum High-density Lipoproteins (1965) (7)
Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a]. (1999) (7)
Further characterization of the human serum D 1.063-1.21, alpha-lipoprotein. (1962) (7)
Factors controlling the release from human blood polymorphonuclear cells in vitro of a proteolytic activity directed against apolipoprotein A-II. (1984) (7)
Hypoalphalipoproteinemia: postprandial response of subjects with preprandial normotriglyceridemia and hypertriglyceridemia to various diets. (1993) (7)
Studies on human serum high-density lipoproteins. Self-association of human serum apolipoprotein A-II in aqueous solutions. (1976) (7)
TRITON HYPERLIPEMIA IN DOGS (1961) (7)
Studies on Human Serum High Density Lipoproteins (2002) (6)
Plasma free fatty acids in dogs treated with Triton WR-1339. (1961) (6)
Domains of apolipoprotein E involved in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and anti-atherogenic properties of this apolipoprotein. (2001) (6)
11 Lipoprotein(a) (1990) (6)
Separation and characterization of the protein moiety of human alpha1-lipoprotein. (1958) (6)
Ultrastructure of serum high density lipoproteins: Facts and models (1978) (5)
Affinity of nonhomologous amphiphilic peptides toward a monoclonal antibody raised against apolipoprotein A‐I (1986) (5)
Lethal effect in dogs of prolonged triparanol oral administration. (1962) (5)
Lipoprotein (a) accumulates intracellularly in coronary atherectomy specimens obtained from primary and restenotic lesions after PTCA (1991) (5)
TRITON HYPERLIPEMIA IN DOGS (1961) (5)
Successful utilization of lyophilized lipoprotein(a) as a biological reagent (2004) (5)
[Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms]. (1996) (5)
ON THE STRUCTURE OF HUMAN SERUM LOW- AND HIGH-DENSITY LIPOPROTEINS. (1972) (5)
An ultracentrifugal study of the self-association of canine apolipoprotein A-I in solution. (1977) (5)
Lipoprotein(a): Nonhuman primate models (1991) (4)
A HIGH RESOLUTION FLUORESCENCE DECAY AND DEPOLARIZATION STUDY OF HUMAN PLASMA APOLIPOPROTEINS (1988) (4)
Viewing the Cardiovascular Pathogenicity of Lp(a) from the Pro-Inflammatory Side (2008) (4)
Comparative Study of Density Distribution of Plasma Lipoproteins of Normoand Hypercholesterolemic Rhesus Monkeys and Humans (1986) (4)
3 – Plasma Apolipoproteins: Gene Structure, Function, and Variants (1987) (4)
Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500239-JLR200 (2005) (4)
Fluorescence polarization studies of human and rhesus A-I apolipoproteins and their complexes with phosphatidylcholine. (1977) (4)
Apolipoprotein A-II and Serum High-Density Lipoproteins: A Model System for the Study of Protein-Lipid Interactions at a Natural Hydrophilic-Hydrophobic Interface. (1982) (3)
Lipoprotein(a), Friedewald formula, and NCEP guidelines. National Cholesterol Education Program. (2001) (3)
Interactions of a fluorescently labeled peptide with kringle domains in proteins (1993) (3)
Interaction of serum lipoproteins with heparin and phenol. (1957) (3)
Apolipoprotein B-100 of plasma low density lipoproteins undergoes proteolysis by contact activation factors when plasma is treated with dextran sulfate-500-MgCl2. (1989) (3)
Lipoprotein disorders: diagnosis and treatment (1989) (3)
Lipoprotein disorders as related to atherosclerotic cardiovascular disease. (1995) (3)
Ultracentrifugal behavior of apolipoprotein A-I of rhesus monkey (Macaca mulatta). (1976) (3)
Human leukocyte proliferation in vitro to purified staphylococcal protein A. (1971) (3)
Polypeptide A-II of serum high density lipoproteins: a lipophilic protein of phylogenetic interest. [Man, rhesus monkey, baboon, squirrel monkey, Cebus monkey, gibbon] (1975) (3)
Human plasma high density lipoproteins. (1971) (3)
Mouse Plasminogen Has Oxidized Phosphatidylcholine Adducts That Are Not Metabolized by Lipoprotein-Associated Phospholipase A2 under Basal Conditions (2010) (3)
Apolipoprotein(a) in the Carotid Artery Plaque: Evidence for Proteolytic and Pro-Inflammatory Modifications (2008) (3)
Lipoprotein(a) further invalidates Friedewald formula. (1994) (3)
Proteolytic modifications of lipoprotein(a): potential relevance to its postulated atherothrombogenic role. (1998) (2)
High-performance liquid chromatography of apolipoproteins. (1986) (2)
Physiopathology of plasma lipoprotein metabolism. (1991) (2)
Polymorphonuclear cells from human peripheral blood, but not lymphocytes, monocytes, or monocyte-derived macrophages, cause the in vitro hydrolysis of apolipoprotein A-II of serum high density lipoproteins. (1982) (2)
Structure of human serum lipoproteins. (1972) (2)
The structure of plasma low density lipoproteins: Experimental facts and interpretations—A minireview (1980) (1)
Lp(a) as a cardiovascular risk factor (1991) (1)
Plasma lipoproteins: concepts and trends. (1971) (1)
Environmental Effects on the Structure of Human Serum High Density Lipoprotein and Its Apoprotein (1969) (1)
The apoB 100-apo(a) complex: relation to triglyceride-rich particles. (1991) (1)
Practical diagnostic aids in the study of dyslipoproteinemias. (1970) (1)
Lipids in Evolution (review) (2015) (1)
Plasma protein turnover: edited by R. Bianchi, G. Mariani and A. S. McFarlane, published by MacMillan Press Ltd., London and Basingstoke, 1976. £17.50 (approx. $34.-) (451 pages) (1976) (1)
X-ray and neutron small-angle scattering studies of human serum lipoproteins. (1976) (1)
Plasma Protein Turnover, R. Bianchi, G. Mariani, A.S. McFarlane (Eds.). MacMillan Press Ltd., London (1976) (1976) (1)
A quantitative immunoassay for the lysine binding function of lipoprotein(a) in plasma (1994) (1)
Effect on rat ovary granulosa cell steroidogenesis of high density lipoprotein with varying ratios of apo A-I and APO A-II (1984) (1)
Structure ofhumanserumlipoproteins inferred fromcompositional (1977) (1)
Rapid fractionation of human high density apolipoproteins by high performance liquid chromatography (1981) (1)
Molecular Basis for the Lysine Binding Polymorphism of Lipoprotein(a) (1995) (1)
Human plasma high-density lipoproteins: past, present and future. (1971) (1)
Cleavage of Human Apolipoprotein(a) Coated on the Surface of Consituents of the Vascular Extracellular Matrix by Pancreatic Elastase and Metalloproteinase-12. Different Partitions Between Cleaved NTerminal and C-Terminal Domains (2004) (1)
POLYPEPTIDES OF HUMAN SERUM LIPOPROTEIN AND THEIR CLINICAL SIGNIFICANCE. (1972) (1)
Rhesus Monkey Lipoprotein (a) (1994) (1)
On the Role of Apolipoprotein A-I in the Structure of Serum High-Density Lipoproteins (HDL) (1977) (0)
Membrane Biochemistry By Edith Sim, and: Dynamics of Biological Membranes: Influence on Synthesis, Structure and Function By Miles D. Houslan and Keith K. Stanley (review) (2015) (0)
a mm A PUBLICATION OF THE AMERICAN OIL CHEMISTS' SOCIETY (1988) (0)
Effect of triton WR-1339 on the heparin-induced plasma lipoprotein lipase activity in dogs. (1963) (0)
Nonhuman Primate Models (0)
Lp [a]: A Lipoprotein Class with Atherothrombotic Potential (1992) (0)
Oxidized phospholipids modify plasminogen and apolipoprotein(a): Implications for vascular disease * (2012) (0)
In Vitro Effect of Thiol- and Cysteine-Containing Compounds on the Immunological Reactivity of Human and Rhesus Monkey Lipoprotein(a) (1993) (0)
Impact of technology on the plasma lipoprotein field. (1986) (0)
Fibrinolytic, Platelet and Monocyte Variables in Homozygous Familial Hypercholesterolemia. The Effect of a Regular Plasma Cholesterol Removal by LDL-apheresis (1993) (0)
Lipoprotein(a) and the Artery Wall (2007) (0)
Reply (1991) (0)
Surface Organization of the Apolipoproteins of Plasma High Density Lipoproteins and Relevance to Functions (1983) (0)
Molecular weight and subunit structure of human serum high density lipoproteinafter chemical modifications by succinic anhydride. (1968) (0)
Plasma lipoprotein(a) levels in LDL receptor deficient rhesus monkey. (1996) (0)
The polypeptides of human serum lipoproteins and their clinical significance. (1972) (0)
Plasma low density lipoproteins (1977) (0)
2.P.100 The in vivo of metabolism of free-Apo(a) in normals and subjects with abetalipoproteinemia (1997) (0)
Phosphatidylcholine: Biochemical and clinical aspects of essential phospholipids: edited by H. Peelers, published by Springer-Verlag, Berlin, 1976. DM 38.- ($15.60) (viii+254 pages) (1977) (0)
Meeting Summary Workshop on Apolipoprotein Quantification (2005) (0)
[Research on the hypoglycemic action of PAS]. (1952) (0)
Isolation and Characterization of the Three Major Low Density Lipoproteins from Normolipidemic Rhesus Monkeys ( 1 Macaca muZutta ) * (2002) (0)
Small angle X-ray scattering of human serum low density lipoproteins. (1971) (0)
Fibrinogen Binding of Lipoprotein(A) Does Not Require an Active Lysine Binding Site in Apolipoprotein(A) Kringleiv-10 (1996) (0)
Blood Lipids and Lipoproteins. Quantitation, Composition, and Metabolism. Gary J. Nelson, Ed. Wiley-Interscience, New York, 1972. xii, 980 pp., illus. $39.95 (1973) (0)
On the role of genetic factors in coronary heart disease. (1991) (0)
Blood Constituents: Blood Lipids and Lipoproteins . Quantitation, Composition, and Metabolism. Gary J. Nelson, Ed. Wiley-Interscience, New York, 1972. xii, 980 pp., illus. $39.95. (1973) (0)
Hypobetalipoproteinemia (1974) (0)
RECOMBINANT KRINGLE IV-10/W72R MUTANT OF HUMAN APOLIPOPROTEIN(A) (1999) (0)
A study of the polypeptides of serum lipoproteins in hypo- -lipoproteinemia. (1971) (0)
Abetalipoproteinemia and hypobetalipoproteinemia: what is the primary defect? (1978) (0)
I. IN VITRO EFFECTS OF TIrE DETERGENT ON SERUM LIPOPROTEINS AND CHYLOMICRONS (1960) (0)
Chapter 12 – The Rhesus Monkey as a Model for the Study of Lp(a) (1990) (0)
Lipoprotein(a) as an Athero-Antifibrinolytic Risk Factor (1992) (0)
Familial hypoalphalipoproteinemia: definition of two groups based on plasma triglyceride levels. (1989) (0)
Lipoprotein(a) and the arterial wall (2007) (0)
Conspectus on the role of genetic factors in coronary heart disease (1991) (0)
RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) (1999) (0)
Phospholipases as Structural and Functional Probes for Circulating Lipoproteins (1977) (0)
HIGH DENSITY LIPOPROTEIN AND ITS APOPROTEIN (1969) (0)
Evidence for a partial deficiency of the LDL (apo B,E) receptor within a family of rhesus monkeys with a spontaneous hypercholesterolemia (1987) (0)
Solubility requirements for cholesterol esters in human plasma: role of high density lipoprotein protein and phospholipids. (1972) (0)
Intrinsic value with drawbacks (1978) (0)
Lipoprotein(a): a genetically-determined lipoprotein variant in which a protein of the plasminogen family is linked to APO B100. (1987) (0)
INTRODUCTORY REMARKS (1980) (0)
Mo-W4:7 Acute effects of lipoprotein(A) in an experimental model of cerebral stroke (2006) (0)
LP(A): A link between thrombosis and atherosclerosis (1992) (0)
GENERAL DISCUSSION (1980) (0)
FACTORS CONTRIBUTING TO PREMATURE CARDIOVASCULAR DISEASE IN NORMOCHOLESTEROLEMIC STATE (1997) (0)
Lipoprotein(a) and the LDL receptor (LDL-R): examination of the problem in a pedigree of rhesus monkeys with a familial hypercholesterolemia secondary to LDL-R deficiency (1990) (0)
Serum Lp(a) level in normal, atherosclerotic and diabetic individuals in a Chinese population (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Angelo M. Scanu?

Angelo M. Scanu is affiliated with the following schools:

Angelo M. Scanu's Academic­Influence.com Rankings

Angelo M. Scanu's Degrees

Why Is Angelo M. Scanu Influential?

Angelo M. Scanu's Published Works

Published Works

What Schools Are Affiliated With Angelo M. Scanu?

Angelo M. Scanu's AcademicInfluence.com Rankings